Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying DiseaseRomain Lécuyer, David Boutoille, Nahéma Issa et al.|CHEST Journal|2024Cited by 49
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of <i>Pneumocystis jirovecii</i> PneumoniaRomain Lécuyer, Nahéma Issa, Stéphane Corvec et al.|The Journal of Infectious Diseases|2021Cited by 36
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R. Power, Anju Nohria, Lauren A. Baldassarre et al.|European Heart Journal|2025Cited by 34
Outcomes in Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation RecipientsAntoine Lafarge, Élie Azoulay, Christian Récher et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 16
Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective studyFlorian Reizine, Noémie Coron, Soraya Benguerfi et al.|Annals of Intensive Care|2025Cited by 4